| State | Name as filed |
|---|---|
| OR | Bako Pathology |
| State | Agency | Source key | Raw status | Status | Stage | Review type |
|---|---|---|---|---|---|---|
| OR | Oregon Health Authority | 072 | Approved | APPROVED | PRELIMINARY | Preliminary Review |
| CA | Office of Health Care Affordability (HCAI) | mcn-inform-diagnostics | CMIR Waived | WAIVED | NOTICE | Inform Diagnostics, Inc. and Fulgent Therapeutics, LLC will acquire equity interests of Dermatopathology Experts, LLC and all assets related to the diagnostic and therapeutic services of Bako Pathology Holdings Corp. and its subsidiaries. |
| Date | Date kind | Event | Raw text | Source |
|---|---|---|---|---|
| 2026-01-07 | PUBLISHED | NOTICE_ACCEPTED | Date Submission Completed: January 7, 2026 | CA agency page |
| 2026-03-16 | PUBLISHED | OTHER | OHA completed a 30-day preliminary review of this transaction on March 16, 2026. | OR agency page |
| not dated | PUBLISHED | CMIR_WAIVED | CMIR Waived | CA agency page |
| Source | Captured at (UTC) |
|---|---|
| https://www.oregon.gov/oha/HPA/HP/Pages/HCMO-transaction-notices-and-reviews.aspx | 2026-09-26T11:15:31.315Z |
| https://www.oregon.gov/oha/HPA/HP/Pages/072-informdx-bako.aspx | 2026-09-26T07:10:36.031Z |
| https://hcai.ca.gov/affordability/ohca/assess-market-consolidation/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir/ | 2026-09-26T11:15:42.293Z |